Search research articles
Contact Us
Filters
Showing results (161-170 of 233) with videos related to
Page
of 24
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1990
Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action
D D Schoepp, P L Ornstein, J D Leander, et al.
Neuron
|
November 24, 2001
A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP
S E Lauri, Z A Bortolotto, D Bleakman, et al.
Journal of Medicinal Chemistry
|
January 1, 1991
4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action
P L Ornstein, D D Schoepp, M B Arnold, et al.
Journal of Medicinal Chemistry
|
December 8, 1995
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist
P L Ornstein, M B Arnold, N K Allen, et al.
Neuropharmacology
|
December 16, 1998
Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord
M J Procter, A K Houghton, E S Faber, et al.
Journal of Medicinal Chemistry
|
August 21, 1992
NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomer
P L Ornstein, D D Schoepp, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists
P L Ornstein, M B Arnold, W H Lunn, et al.
Neuropharmacology
|
December 16, 1998
Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia
M J O'Neill, A Bond, P L Ornstein, et al.
Molecular Pharmacology
|
April 1, 1996
Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid
R Bleakman, D D Schoepp, B Ballyk, et al.
Military Medicine
|
March 27, 2001
Treatment of severe thrombocytopenia in alloimmunized, transfusion-refractory patients
D L Ornstein, K L Mortara, M B Smith, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 233) with videos related to
Sort By:
Page
of 24
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1990
Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action
D D Schoepp, P L Ornstein, J D Leander, et al.
Neuron
|
November 24, 2001
A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP
S E Lauri, Z A Bortolotto, D Bleakman, et al.
Journal of Medicinal Chemistry
|
January 1, 1991
4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action
P L Ornstein, D D Schoepp, M B Arnold, et al.
Journal of Medicinal Chemistry
|
December 8, 1995
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist
P L Ornstein, M B Arnold, N K Allen, et al.
Neuropharmacology
|
December 16, 1998
Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord
M J Procter, A K Houghton, E S Faber, et al.
Journal of Medicinal Chemistry
|
August 21, 1992
NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomer
P L Ornstein, D D Schoepp, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists
P L Ornstein, M B Arnold, W H Lunn, et al.
Neuropharmacology
|
December 16, 1998
Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia
M J O'Neill, A Bond, P L Ornstein, et al.
Molecular Pharmacology
|
April 1, 1996
Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid
R Bleakman, D D Schoepp, B Ballyk, et al.
Military Medicine
|
March 27, 2001
Treatment of severe thrombocytopenia in alloimmunized, transfusion-refractory patients
D L Ornstein, K L Mortara, M B Smith, et al.
Page
of 24